Curi RMB Capital’s Veracyte VCYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.71M Buy
63,197
+19,137
+43% +$802K 0.06% 270
2026
Q1
$1.42M Buy
44,060
+168
+0.4% +$6.22K 0.03% 388
2025
Q4
$1.85M Buy
43,892
+12
+0% +$484 0.03% 351
2025
Q3
$1.51M Buy
43,880
+5
+0% +$143 0.03% 369
2025
Q2
$1.19M Buy
43,875
+10,590
+32% +$307K 0.02% 392
2025
Q1
$987K Sell
33,285
-3,133
-9% -$119K 0.02% 329
2024
Q4
$1.44M Hold
36,418
– – 0.03% 299
2024
Q3
$1.24M Hold
36,418
– – 0.03% 320
2024
Q2
$789K Hold
36,418
– – 0.02% 357
2024
Q1
$807K Buy
36,418
+8,680
+31% +$212K 0.02% 369
2023
Q4
$763K Hold
27,738
– – 0.02% 330
2023
Q3
$619K Buy
27,738
+7,499
+37% +$193K 0.02% 349
2023
Q2
$515K Hold
20,239
– – 0.02% 370
2023
Q1
$451K Hold
20,239
– – 0.02% 376
2022
Q4
$480K Hold
20,239
– – 0.02% 370
2022
Q3
$336K Hold
20,239
– – 0.01% 396
2022
Q2
$403K Hold
20,239
– – 0.01% 379
2022
Q1
$558K Hold
20,239
– – 0.02% 321
2021
Q4
$834K Hold
20,239
– – 0.03% 300
2021
Q3
$940K Hold
20,239
– – 0.03% 277
2021
Q2
$809K Hold
20,239
– – 0.03% 301
2021
Q1
$1.09M Hold
20,239
– – 0.04% 258
2020
Q4
$990K Hold
20,239
– – 0.04% 312
2020
Q3
$658K Sell
20,239
-2,432
-11% -$77.3K 0.03% 376
2020
Q2
$587K Sell
22,671
-1,293
-5% -$32.2K 0.03% 385
2020
Q1
$583K Buy
23,964
+1,332
+6% +$33.5K 0.03% 374
2019
Q4
$632K Buy
22,632
+5,600
+33% +$145K 0.02% 415
2019
Q3
$409K Hold
17,032
– – 0.01% 513
2019
Q2
$486K Buy
+17,032
New +$425K 0.01% 556

Other funds holding VCYT

Curi RMB Capital's VCYT Position: Q2 2026 in Review

Curi RMB Capital increased its Veracyte (VCYT) stake by 43% in Q2 2026, buying an estimated $802K and bringing the position to 63,197 shares worth $3.71M. The position accounts for 0.06% of the portfolio, ranked #270.

Curi RMB Capital first reported a position in VCYT in Q2 2019 and has held it in 29 quarters since. 370 funds tracked by Wall St. Rank hold VCYT as of Q2 2026.

  • Curi RMB Capital held 63,197 shares of Veracyte worth $3.71M as of Q2 2026.
  • Curi RMB Capital bought 19,137 Veracyte shares in Q2 2026, an estimated $802K.
  • Veracyte made up 0.06% of Curi RMB Capital's portfolio in Q2 2026, its #270 holding.
  • Curi RMB Capital first reported a position in Veracyte in Q2 2019 and has held it in 29 quarters since.
  • 370 funds tracked by Wall St. Rank held Veracyte as of Q2 2026.

Based on Curi RMB Capital's 13F filing for Q2 2026, filed 14 Aug 2026.